Stefanie F Valbon, Marie-Eve Lebel, H Alex Feldman, Stephanie A Condotta, Mengqi Dong, Daniela Giordano, Stephen N Waggoner, Heather J Melichar, Martin J Richer
{"title":"Type I interferon induced during chronic viral infection favors B-cell development in the thymus","authors":"Stefanie F Valbon, Marie-Eve Lebel, H Alex Feldman, Stephanie A Condotta, Mengqi Dong, Daniela Giordano, Stephen N Waggoner, Heather J Melichar, Martin J Richer","doi":"10.1111/imcb.12808","DOIUrl":null,"url":null,"abstract":"<p>Chronic viral infections cause thymic involution yet the potential for broader, longer-term impact on thymic composition remains unexplored. Here we show that chronic, but not acute, lymphocytic choriomeningitis virus infection promotes a unique population of immature B cells in the thymus. We show that chronic viral infection promotes signals within the thymus, including the expression of B-cell activating factor (BAFF), that favor the maturation of this population as these cells acquire expression of CD19 and immunoglobulin M. Mechanistically, type I interferon (IFN-I), predominantly IFNβ, signals to thymic hematopoietic cells, strongly delaying T-cell development at the earliest precursor stage. Furthermore, IFN-I signaling to the nonhematopoietic compartment provides a second signal essential to favor B-cell differentiation and maturation within the thymus. Importantly, chronic infection yields changes in the B-cell population for at least 50 days following infection, long after thymic atrophy has subsided. Thus, the inflammatory milieu induced by chronic viral infection has a profound, and long-lasting, effect on thymic composition leading to the generation of a novel population of thymic B cells.</p>","PeriodicalId":179,"journal":{"name":"Immunology & Cell Biology","volume":"102 9","pages":"801-816"},"PeriodicalIF":3.2000,"publicationDate":"2024-07-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11444890/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Immunology & Cell Biology","FirstCategoryId":"2","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/imcb.12808","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"CELL BIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Chronic viral infections cause thymic involution yet the potential for broader, longer-term impact on thymic composition remains unexplored. Here we show that chronic, but not acute, lymphocytic choriomeningitis virus infection promotes a unique population of immature B cells in the thymus. We show that chronic viral infection promotes signals within the thymus, including the expression of B-cell activating factor (BAFF), that favor the maturation of this population as these cells acquire expression of CD19 and immunoglobulin M. Mechanistically, type I interferon (IFN-I), predominantly IFNβ, signals to thymic hematopoietic cells, strongly delaying T-cell development at the earliest precursor stage. Furthermore, IFN-I signaling to the nonhematopoietic compartment provides a second signal essential to favor B-cell differentiation and maturation within the thymus. Importantly, chronic infection yields changes in the B-cell population for at least 50 days following infection, long after thymic atrophy has subsided. Thus, the inflammatory milieu induced by chronic viral infection has a profound, and long-lasting, effect on thymic composition leading to the generation of a novel population of thymic B cells.
慢性病毒感染会导致胸腺萎缩,但对胸腺组成产生更广泛、更长期影响的可能性仍有待探索。在这里,我们发现慢性淋巴细胞性脉络膜炎病毒感染(而非急性淋巴细胞性脉络膜炎病毒感染)会促进胸腺中一种独特的未成熟 B 细胞群。从机理上讲,I 型干扰素(IFN-I),主要是 IFNβ,向胸腺造血细胞发出信号,在最早的前体阶段强烈延迟 T 细胞的发育。此外,IFN-I 还向非造血细胞区发出信号,提供了有利于胸腺内 B 细胞分化和成熟所必需的第二个信号。重要的是,在胸腺萎缩消退后的很长一段时间内,慢性感染会在感染后至少 50 天内导致 B 细胞群发生变化。因此,慢性病毒感染诱导的炎症环境对胸腺组成产生了深远而持久的影响,导致胸腺B细胞新群体的产生。
期刊介绍:
The Australasian Society for Immunology Incorporated (ASI) was created by the amalgamation in 1991 of the Australian Society for Immunology, formed in 1970, and the New Zealand Society for Immunology, formed in 1975. The aim of the Society is to encourage and support the discipline of immunology in the Australasian region. It is a broadly based Society, embracing clinical and experimental, cellular and molecular immunology in humans and animals. The Society provides a network for the exchange of information and for collaboration within Australia, New Zealand and overseas. ASI members have been prominent in advancing biological and medical research worldwide. We seek to encourage the study of immunology in Australia and New Zealand and are active in introducing young scientists to the discipline.